In terms of Neogenomics Inc share price expectations, FactSet research, analysts set an average price target of 12 in the next 12 months, up nearly 128.57% from the previous closing price of $5.25. Analysts anticipate Neogenomics Inc stock to reach 12 by 2025, with the lowest price target being 12. In spite of this, 8 analysts ranked Neogenomics Inc stock as Buy at the end of 2025.